Article Details
Retrieved on: 2024-07-12 14:33:20
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses the link between semaglutide, a medication used for diabetes and weight loss, and non-arteritic anterior ischemic optic neuropathy (NAION), an eye condition causing vision loss. This is related to the key concept of 'Neuroscience' through the exploration of how the medication affects neural pathways and its implications for patients with eye diseases. The tags highlight relevant medical conditions and key figures in the field.
Article found on: www.prevention.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here